The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Irbesartan Tablets Market Research Report 2025
Synopsis
Irbesartan is an oral medication that is used to treat high blood pressure (hypertension) and diabetic nephropathy or kidney disease. It belongs to a class of drugs called angiotensin receptor blockers (ARBs).
The global Irbesartan Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Irbesartan Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Irbesartan Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Irbesartan Tablets include Teva, Sanofi, Taj Pharmaceuticals, Apotex, Jiangsu Hengrui Medicine, Zhuhai Rundu Pharmaceutica and Verdant Life Sciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Irbesartan Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Irbesartan Tablets.
Report Scope
The Irbesartan Tablets market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Irbesartan Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Irbesartan Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Sanofi
Taj Pharmaceuticals
Apotex
Jiangsu Hengrui Medicine
Zhuhai Rundu Pharmaceutica
Verdant Life Sciences
Segment by Type
75 mg Tablets
150 mg Tablets
300 mg Tablets
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Irbesartan Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Irbesartan Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Irbesartan is an oral medication that is used to treat high blood pressure (hypertension) and diabetic nephropathy or kidney disease. It belongs to a class of drugs called angiotensin receptor blockers (ARBs).
The global Irbesartan Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Irbesartan Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Irbesartan Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Irbesartan Tablets include Teva, Sanofi, Taj Pharmaceuticals, Apotex, Jiangsu Hengrui Medicine, Zhuhai Rundu Pharmaceutica and Verdant Life Sciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Irbesartan Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Irbesartan Tablets.
Report Scope
The Irbesartan Tablets market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Irbesartan Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Irbesartan Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Sanofi
Taj Pharmaceuticals
Apotex
Jiangsu Hengrui Medicine
Zhuhai Rundu Pharmaceutica
Verdant Life Sciences
Segment by Type
75 mg Tablets
150 mg Tablets
300 mg Tablets
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Irbesartan Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Irbesartan Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Irbesartan Tablets Market Overview
1.1 Product Overview and Scope of Irbesartan Tablets
1.2 Irbesartan Tablets Segment by Type
1.2.1 Global Irbesartan Tablets Market Value Comparison by Type (2024-2030)
1.2.2 75 mg Tablets
1.2.3 150 mg Tablets
1.2.4 300 mg Tablets
1.3 Irbesartan Tablets Segment by Application
1.3.1 Global Irbesartan Tablets Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Irbesartan Tablets Market Size Estimates and Forecasts
1.4.1 Global Irbesartan Tablets Revenue 2019-2030
1.4.2 Global Irbesartan Tablets Sales 2019-2030
1.4.3 Global Irbesartan Tablets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Irbesartan Tablets Market Competition by Manufacturers
2.1 Global Irbesartan Tablets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Irbesartan Tablets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Irbesartan Tablets Average Price by Manufacturers (2019-2024)
2.4 Global Irbesartan Tablets Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Irbesartan Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Irbesartan Tablets, Product Type & Application
2.7 Irbesartan Tablets Market Competitive Situation and Trends
2.7.1 Irbesartan Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Irbesartan Tablets Players Market Share by Revenue
2.7.3 Global Irbesartan Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Irbesartan Tablets Retrospective Market Scenario by Region
3.1 Global Irbesartan Tablets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Irbesartan Tablets Global Irbesartan Tablets Sales by Region: 2019-2030
3.2.1 Global Irbesartan Tablets Sales by Region: 2019-2024
3.2.2 Global Irbesartan Tablets Sales by Region: 2025-2030
3.3 Global Irbesartan Tablets Global Irbesartan Tablets Revenue by Region: 2019-2030
3.3.1 Global Irbesartan Tablets Revenue by Region: 2019-2024
3.3.2 Global Irbesartan Tablets Revenue by Region: 2025-2030
3.4 North America Irbesartan Tablets Market Facts & Figures by Country
3.4.1 North America Irbesartan Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Irbesartan Tablets Sales by Country (2019-2030)
3.4.3 North America Irbesartan Tablets Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Irbesartan Tablets Market Facts & Figures by Country
3.5.1 Europe Irbesartan Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Irbesartan Tablets Sales by Country (2019-2030)
3.5.3 Europe Irbesartan Tablets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Irbesartan Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Irbesartan Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Irbesartan Tablets Sales by Country (2019-2030)
3.6.3 Asia Pacific Irbesartan Tablets Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Irbesartan Tablets Market Facts & Figures by Country
3.7.1 Latin America Irbesartan Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Irbesartan Tablets Sales by Country (2019-2030)
3.7.3 Latin America Irbesartan Tablets Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Irbesartan Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Irbesartan Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Irbesartan Tablets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Irbesartan Tablets Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Irbesartan Tablets Sales by Type (2019-2030)
4.1.1 Global Irbesartan Tablets Sales by Type (2019-2024)
4.1.2 Global Irbesartan Tablets Sales by Type (2025-2030)
4.1.3 Global Irbesartan Tablets Sales Market Share by Type (2019-2030)
4.2 Global Irbesartan Tablets Revenue by Type (2019-2030)
4.2.1 Global Irbesartan Tablets Revenue by Type (2019-2024)
4.2.2 Global Irbesartan Tablets Revenue by Type (2025-2030)
4.2.3 Global Irbesartan Tablets Revenue Market Share by Type (2019-2030)
4.3 Global Irbesartan Tablets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Irbesartan Tablets Sales by Application (2019-2030)
5.1.1 Global Irbesartan Tablets Sales by Application (2019-2024)
5.1.2 Global Irbesartan Tablets Sales by Application (2025-2030)
5.1.3 Global Irbesartan Tablets Sales Market Share by Application (2019-2030)
5.2 Global Irbesartan Tablets Revenue by Application (2019-2030)
5.2.1 Global Irbesartan Tablets Revenue by Application (2019-2024)
5.2.2 Global Irbesartan Tablets Revenue by Application (2025-2030)
5.2.3 Global Irbesartan Tablets Revenue Market Share by Application (2019-2030)
5.3 Global Irbesartan Tablets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Irbesartan Tablets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Teva Irbesartan Tablets Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Irbesartan Tablets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Irbesartan Tablets Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Taj Pharmaceuticals
6.3.1 Taj Pharmaceuticals Corporation Information
6.3.2 Taj Pharmaceuticals Description and Business Overview
6.3.3 Taj Pharmaceuticals Irbesartan Tablets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Taj Pharmaceuticals Irbesartan Tablets Product Portfolio
6.3.5 Taj Pharmaceuticals Recent Developments/Updates
6.4 Apotex
6.4.1 Apotex Corporation Information
6.4.2 Apotex Description and Business Overview
6.4.3 Apotex Irbesartan Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Apotex Irbesartan Tablets Product Portfolio
6.4.5 Apotex Recent Developments/Updates
6.5 Jiangsu Hengrui Medicine
6.5.1 Jiangsu Hengrui Medicine Corporation Information
6.5.2 Jiangsu Hengrui Medicine Description and Business Overview
6.5.3 Jiangsu Hengrui Medicine Irbesartan Tablets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Jiangsu Hengrui Medicine Irbesartan Tablets Product Portfolio
6.5.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.6 Zhuhai Rundu Pharmaceutica
6.6.1 Zhuhai Rundu Pharmaceutica Corporation Information
6.6.2 Zhuhai Rundu Pharmaceutica Description and Business Overview
6.6.3 Zhuhai Rundu Pharmaceutica Irbesartan Tablets Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Zhuhai Rundu Pharmaceutica Irbesartan Tablets Product Portfolio
6.6.5 Zhuhai Rundu Pharmaceutica Recent Developments/Updates
6.7 Verdant Life Sciences
6.6.1 Verdant Life Sciences Corporation Information
6.6.2 Verdant Life Sciences Description and Business Overview
6.6.3 Verdant Life Sciences Irbesartan Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Verdant Life Sciences Irbesartan Tablets Product Portfolio
6.7.5 Verdant Life Sciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Irbesartan Tablets Industry Chain Analysis
7.2 Irbesartan Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Irbesartan Tablets Production Mode & Process
7.4 Irbesartan Tablets Sales and Marketing
7.4.1 Irbesartan Tablets Sales Channels
7.4.2 Irbesartan Tablets Distributors
7.5 Irbesartan Tablets Customers
8 Irbesartan Tablets Market Dynamics
8.1 Irbesartan Tablets Industry Trends
8.2 Irbesartan Tablets Market Drivers
8.3 Irbesartan Tablets Market Challenges
8.4 Irbesartan Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Irbesartan Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Irbesartan Tablets Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Irbesartan Tablets Market Competitive Situation by Manufacturers in 2023
Table 4. Global Irbesartan Tablets Sales (Kg) of Key Manufacturers (2019-2024)
Table 5. Global Irbesartan Tablets Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Irbesartan Tablets Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Irbesartan Tablets Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Irbesartan Tablets Average Price (USD/g) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Irbesartan Tablets, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Irbesartan Tablets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Irbesartan Tablets, Product Type & Application
Table 12. Global Key Manufacturers of Irbesartan Tablets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Irbesartan Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irbesartan Tablets as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Irbesartan Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Irbesartan Tablets Sales by Region (2019-2024) & (Kg)
Table 18. Global Irbesartan Tablets Sales Market Share by Region (2019-2024)
Table 19. Global Irbesartan Tablets Sales by Region (2025-2030) & (Kg)
Table 20. Global Irbesartan Tablets Sales Market Share by Region (2025-2030)
Table 21. Global Irbesartan Tablets Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Irbesartan Tablets Revenue Market Share by Region (2019-2024)
Table 23. Global Irbesartan Tablets Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Irbesartan Tablets Revenue Market Share by Region (2025-2030)
Table 25. North America Irbesartan Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Irbesartan Tablets Sales by Country (2019-2024) & (Kg)
Table 27. North America Irbesartan Tablets Sales by Country (2025-2030) & (Kg)
Table 28. North America Irbesartan Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Irbesartan Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Irbesartan Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Irbesartan Tablets Sales by Country (2019-2024) & (Kg)
Table 32. Europe Irbesartan Tablets Sales by Country (2025-2030) & (Kg)
Table 33. Europe Irbesartan Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Irbesartan Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Irbesartan Tablets Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Irbesartan Tablets Sales by Region (2019-2024) & (Kg)
Table 37. Asia Pacific Irbesartan Tablets Sales by Region (2025-2030) & (Kg)
Table 38. Asia Pacific Irbesartan Tablets Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Irbesartan Tablets Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Irbesartan Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Irbesartan Tablets Sales by Country (2019-2024) & (Kg)
Table 42. Latin America Irbesartan Tablets Sales by Country (2025-2030) & (Kg)
Table 43. Latin America Irbesartan Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Irbesartan Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Irbesartan Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Irbesartan Tablets Sales by Country (2019-2024) & (Kg)
Table 47. Middle East & Africa Irbesartan Tablets Sales by Country (2025-2030) & (Kg)
Table 48. Middle East & Africa Irbesartan Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Irbesartan Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Irbesartan Tablets Sales (Kg) by Type (2019-2024)
Table 51. Global Irbesartan Tablets Sales (Kg) by Type (2025-2030)
Table 52. Global Irbesartan Tablets Sales Market Share by Type (2019-2024)
Table 53. Global Irbesartan Tablets Sales Market Share by Type (2025-2030)
Table 54. Global Irbesartan Tablets Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Irbesartan Tablets Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Irbesartan Tablets Revenue Market Share by Type (2019-2024)
Table 57. Global Irbesartan Tablets Revenue Market Share by Type (2025-2030)
Table 58. Global Irbesartan Tablets Price (USD/g) by Type (2019-2024)
Table 59. Global Irbesartan Tablets Price (USD/g) by Type (2025-2030)
Table 60. Global Irbesartan Tablets Sales (Kg) by Application (2019-2024)
Table 61. Global Irbesartan Tablets Sales (Kg) by Application (2025-2030)
Table 62. Global Irbesartan Tablets Sales Market Share by Application (2019-2024)
Table 63. Global Irbesartan Tablets Sales Market Share by Application (2025-2030)
Table 64. Global Irbesartan Tablets Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Irbesartan Tablets Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Irbesartan Tablets Revenue Market Share by Application (2019-2024)
Table 67. Global Irbesartan Tablets Revenue Market Share by Application (2025-2030)
Table 68. Global Irbesartan Tablets Price (USD/g) by Application (2019-2024)
Table 69. Global Irbesartan Tablets Price (USD/g) by Application (2025-2030)
Table 70. Teva Corporation Information
Table 71. Teva Description and Business Overview
Table 72. Teva Irbesartan Tablets Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 73. Teva Irbesartan Tablets Product
Table 74. Teva Recent Developments/Updates
Table 75. Sanofi Corporation Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Irbesartan Tablets Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 78. Sanofi Irbesartan Tablets Product
Table 79. Sanofi Recent Developments/Updates
Table 80. Taj Pharmaceuticals Corporation Information
Table 81. Taj Pharmaceuticals Description and Business Overview
Table 82. Taj Pharmaceuticals Irbesartan Tablets Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 83. Taj Pharmaceuticals Irbesartan Tablets Product
Table 84. Taj Pharmaceuticals Recent Developments/Updates
Table 85. Apotex Corporation Information
Table 86. Apotex Description and Business Overview
Table 87. Apotex Irbesartan Tablets Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 88. Apotex Irbesartan Tablets Product
Table 89. Apotex Recent Developments/Updates
Table 90. Jiangsu Hengrui Medicine Corporation Information
Table 91. Jiangsu Hengrui Medicine Description and Business Overview
Table 92. Jiangsu Hengrui Medicine Irbesartan Tablets Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 93. Jiangsu Hengrui Medicine Irbesartan Tablets Product
Table 94. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 95. Zhuhai Rundu Pharmaceutica Corporation Information
Table 96. Zhuhai Rundu Pharmaceutica Description and Business Overview
Table 97. Zhuhai Rundu Pharmaceutica Irbesartan Tablets Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 98. Zhuhai Rundu Pharmaceutica Irbesartan Tablets Product
Table 99. Zhuhai Rundu Pharmaceutica Recent Developments/Updates
Table 100. Verdant Life Sciences Corporation Information
Table 101. Verdant Life Sciences Description and Business Overview
Table 102. Verdant Life Sciences Irbesartan Tablets Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 103. Verdant Life Sciences Irbesartan Tablets Product
Table 104. Verdant Life Sciences Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Irbesartan Tablets Distributors List
Table 108. Irbesartan Tablets Customers List
Table 109. Irbesartan Tablets Market Trends
Table 110. Irbesartan Tablets Market Drivers
Table 111. Irbesartan Tablets Market Challenges
Table 112. Irbesartan Tablets Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Irbesartan Tablets
Figure 2. Global Irbesartan Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Irbesartan Tablets Market Share by Type in 2023 & 2030
Figure 4. 75 mg Tablets Product Picture
Figure 5. 150 mg Tablets Product Picture
Figure 6. 300 mg Tablets Product Picture
Figure 7. Global Irbesartan Tablets Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Irbesartan Tablets Market Share by Application in 2023 & 2030
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Online Pharmacies
Figure 12. Global Irbesartan Tablets Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Irbesartan Tablets Market Size (2019-2030) & (US$ Million)
Figure 14. Global Irbesartan Tablets Sales (2019-2030) & (Kg)
Figure 15. Global Irbesartan Tablets Average Price (USD/g) & (2019-2030)
Figure 16. Irbesartan Tablets Report Years Considered
Figure 17. Irbesartan Tablets Sales Share by Manufacturers in 2023
Figure 18. Global Irbesartan Tablets Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Irbesartan Tablets Players: Market Share by Revenue in 2023
Figure 20. Irbesartan Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Irbesartan Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Irbesartan Tablets Sales Market Share by Country (2019-2030)
Figure 23. North America Irbesartan Tablets Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Irbesartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Irbesartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Irbesartan Tablets Sales Market Share by Country (2019-2030)
Figure 27. Europe Irbesartan Tablets Revenue Market Share by Country (2019-2030)
Figure 28. Germany Irbesartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Irbesartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Irbesartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Irbesartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Irbesartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Irbesartan Tablets Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Irbesartan Tablets Revenue Market Share by Region (2019-2030)
Figure 35. China Irbesartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Irbesartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Irbesartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Irbesartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Irbesartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Irbesartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Irbesartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Irbesartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Irbesartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Irbesartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Irbesartan Tablets Sales Market Share by Country (2019-2030)
Figure 46. Latin America Irbesartan Tablets Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Irbesartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Irbesartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Irbesartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Irbesartan Tablets Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Irbesartan Tablets Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Irbesartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Irbesartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. U.A.E Irbesartan Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Irbesartan Tablets by Type (2019-2030)
Figure 56. Global Revenue Market Share of Irbesartan Tablets by Type (2019-2030)
Figure 57. Global Irbesartan Tablets Price (USD/g) by Type (2019-2030)
Figure 58. Global Sales Market Share of Irbesartan Tablets by Application (2019-2030)
Figure 59. Global Revenue Market Share of Irbesartan Tablets by Application (2019-2030)
Figure 60. Global Irbesartan Tablets Price (USD/g) by Application (2019-2030)
Figure 61. Irbesartan Tablets Value Chain
Figure 62. Irbesartan Tablets Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
